-+ 0.00%
-+ 0.00%
-+ 0.00%

Jinshi Asia Pharmaceutical announced that Jinshi Technology, a wholly-owned first-level subsidiary of the company, signed the “Mask Edition High-Performance Coating Equipment R&D Project “Two-way Unveiling and Leading Project Status Agreement”. The total investment of the project is 30 million yuan. Jinshi Technology is estimated to bear the equipment manufacturing R&D expenses of no less than 18 million yuan. The project implementation period is from March 2026 to June 2027.

Zhitongcaijing·09/23/2026 10:33:10
Listen to the news
Jinshi Asia Pharmaceutical announced that Jinshi Technology, a wholly-owned first-level subsidiary of the company, signed the “Mask Edition High-Performance Coating Equipment R&D Project “Two-way Unveiling and Leading Project Status Agreement”. The total investment of the project is 30 million yuan. Jinshi Technology is estimated to bear the equipment manufacturing R&D expenses of no less than 18 million yuan. The project implementation period is from March 2026 to June 2027.